Andrew Ritter
Board Member
GT Biopharma, Inc. (GTBP)Equibles does not estimate personal net worth.
Get an email with a short summary when GT Biopharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get GTBP alertsAbout Andrew Ritter
Andrew Ritter is recorded as Board Member at GT Biopharma, Inc. (GTBP) since May 8, 2025. GT Biopharma, Inc. reported in an 8-K filed June 11, 2025 that Andrew Ritter resigned as member of the board of directors, effective June 9, 2025. GT Biopharma, Inc. reported in an 8-K filed May 13, 2025 that Andrew Ritter was appointed non-employee director, effective May 8, 2025. GT Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at GT Biopharma, Inc. includes Anthony Cataldo (CEO), Dr. Gregory Berk (CEO), Michael Breen (CEO and Board Member) and 7 others.
“On June 9, 2025, Andrew Ritter resigned as a member of the board of directors (the "Board") of the Company and all committees thereof.”
“On May 8, 2025, the Board appointed Andrew Ritter as a non-employee director to fill one of the vacancies on the Board.”
Affiliation history
-
Current
2025-05-08–present
-
2025-05-08–2025-06-09
Company network
Leadership on record at GT Biopharma, Inc.
- Anthony Cataldo CEO
- Dr. Gregory Berk CEO
- Michael Breen CEO, Board Member
- Bruce Wendel Chairman
- Alan L. Urban CFO, Board Member
- Alan Urban CFO
- Dr. Gavin Choy CFO
- Michael Handelman CFO
- Charles J. Casamento Board Member
- David C. Mun-Gavin Board Member